What Epitel does

Epitel is a privately held digital health company headquartered in Salt Lake City, Utah, that develops wireless EEG (electroencephalography) monitoring systems for seizure detection in neurological care. The company's core product, the REMI Remote EEG Monitoring System, is a truly wireless, wearable platform consisting of four single-use, disposable sensors with eight electrodes forming a 10-channel montage, capable of continuous EEG capture for up to 30 days in both hospital and ambulatory settings. REMI is FDA-cleared for adult and pediatric patients (1+ years) and transmits data through REMI Mobile software to a secure REMI Cloud for review on Persyst Mobile, the dominant EEG viewing platform used by neurologists.

The company's AI offering, REMI Vigilenz AI for Event Detection, is an FDA-cleared software module (2024) that automatically identifies potential electrographic seizure activity in REMI EEG recordings and annotates detected events with tiered confidence levels (Very High 95-100% through Low 0-49%). The model was trained on a clinical validation dataset of 50 patient records covering over 2,600 hours of EEG activity and 87 known seizures, achieving 86.2% event-level sensitivity and 0.162 false alarms per hour in validation. The company holds 11 active US patents covering both REMI and a secondary Epilog sensor product line, and operates with SOC 2 Type 2 + HIPAA + GDPR compliance.

Epitel generates revenue through a combination of hardware sales (single-use disposable sensors) and recurring subscription software (REMI Vigilenz AI), with the system reimbursable via preexisting codes. The company targets emergency rooms, intensive care units, and hospitals for rapid EEG initiation in critical care use cases, and ambulatory/outpatient settings for extended seizure monitoring (addressing the limitations of traditional 72-hour wired EEG). The company sells directly to healthcare facilities through enterprise sales and has raised approximately $15.6 million in venture capital ($12.5M Series A in February 2022 plus a ~$3.12M exempt offering in March 2025), with notable investors including Genoa Ventures, Catalyst Health Ventures, OSF Ventures, Dexcom Ventures, MedMountain Ventures, SLC Angels, and Wavemaker 360 Health. Earlier funding included NIH grants totaling approximately $7.8 million and a $100,000 Ideaship investment.

Name

Epitel

Legal name

Epitel, Inc.

Website

https://epitel.com

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

11–50 employees

Short description

Epitel is a privately held digital health company that develops the REMI wireless EEG monitoring system and REMI Vigilenz AI for seizure detection, serving emergency rooms, ICUs, hospitals, and ambulatory patients in the U.S. neurology market.

Ownership category

akta.pro rank

Product category

Neurological Monitoring Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables) (HLAHACAE)

akta.pro secondary industries

Neurology Telemedicine Platforms (HLALAGAC), Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration) (HLACAPAI)

Keywords

• Wireless EEG monitoring
• Seizure detection devices
• Wearable neurological sensors
• Medical device AI
• Ambulatory EEG systems

Headquarters

HQ city

Salt Lake City

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. REMI EEG Monitoring System: Sale of wireless EEG monitoring system including sensors and software. Sensors are single-use, disposable, and wearable. The system is reimbursable using preexisting codes.
2. REMI Vigilenz AI Software: AI-powered event detection software for EEG analysis. FDA-cleared as medical device software that provides notifications to medical professionals.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels3 records

Core offering

Epitel designs, manufactures, and sells the REMI Remote EEG Monitoring System, a truly wireless wearable EEG platform consisting of 4 single-use disposable sensors that capture brain electrical activity and wirelessly transmit data via the REMI Mobile app and REMI Cloud. The system is FDA-cleared for use in both healthcare facilities (hospitals, ERs, ICUs) and ambulatory settings in adult and pediatric patients (1+ years), supporting monitoring for up to 30 days. The company also offers REMI Vigilenz AI for Event Detection, an FDA-cleared AI software module that automatically identifies potential electrographic seizure activity within EEG recordings and provides tiered confidence-level annotations.

Product overview

Epitel offers a wireless EEG monitoring platform centered on the REMI Remote EEG Monitoring System, a truly wireless wearable solution for seizure detection. The core REMI system consists of 4 disposable sensors with 8 electrodes creating a 10-channel montage, capable of continuous monitoring for up to 30 days. The platform operates through REMI Mobile software and REMI Cloud, with data review via Persyst Mobile. An add-on module, REMI Vigilenz AI for Event Detection, provides AI-powered seizure event detection with confidence scoring. A secondary product line called Epilog also exists, sharing patents with REMI. The system is FDA-cleared for both healthcare facility and ambulatory use.

Differentiator

Problem solved

Functional benefit

Brands

• REMI: Wireless EEG monitoring system for seizure detection in healthcare facilities and ambulatory settings
• REMI Vigilenz AI
• Epilog

Products and services

• REMI Remote EEG Monitoring System A wireless, wearable EEG monitoring platform consisting of 4 single-use disposable sensors (8 electrodes creating a 10-channel montage) that capture and transmit brain electrical activity for up to 30 days. FDA-cleared for in-hospital and ambulatory use in adult and pediatric patients (1+ years), enabling continuous seizure monitoring with remote neurologist review via Persyst Mobile integration. Targets hospitals, emergency rooms, ICUs, and ambulatory/outpatient settings.
• REMI Vigilenz AI for Event Detection FDA-cleared AI-powered analysis module for the REMI system that automatically identifies potential electrographic seizure activity within EEG records. Annotates EEG recordings with detected events along with confidence levels (Very High 95-100%, High 80-94%, Moderate 50-79%, Low 0-49%) and duration. Validated at 86.2% event-level sensitivity and 0.162 false alarms per hour. Indicated for adult and pediatric patients (6+ years).
• Epilog A wireless EEG sensor product line for seizure monitoring, covered by the same patent portfolio as REMI (US11,633,139; US11,638,551). Includes Epilog sensors, stickers, and config software. Components may be sold individually or as part of a system.

Quantifiable outcome

• 86.2% event-level sensitivity and 0.162 false alarms per hour in clinical validation
• +3 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability2 records

Feature4 records

Partnerships

Five partnerships are on record, tiered core and minor.

• Persyst MobilecoreTechnology or IntegrationIntegration partnership where REMI transmits data to Persyst Mobile, the most common EEG monitoring platform, for remote review by healthcare professionals.
• Prescient AssurancecoreImplementation/ SI/ Consulting PartnerThird-party security and compliance attestation provider. Epitel achieved SOC 2 Type 2 + HIPAA + GDPR Compliance Attestation via Prescient Assurance.
• Health-ISACminorStrategic or Co-development PartnerActive member of Health-ISAC, a community committed to cybersecurity threat identification and mitigation in healthcare through information sharing.
• Amazon Web ServicescoreTechnology or IntegrationAWS is a subprocessors providing infrastructure hosting for Epitel's product suite.
• CobaltminorImplementation/ SI/ Consulting PartnerPenetration testing provider used by Epitel for testing hardware and software components including server and cloud environments.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Emerging players

• Empatica: Wearable biosensor company with FDA-cleared Embrace device for epilepsy seizure detection (consumer/ambulatory). Comparable on wearable neurological monitoring form factor and seizure detection use case, though positioned in consumer/ambulatory rather than hospital settings.
• iCE Neurosystems (now Beacon Biosignals): Neurotechnology company focused on continuous EEG monitoring and AI analytics for ICU and inpatient neurology. Comparable on wireless/neuromonitoring + AI seizure detection stack; competes in the same in-hospital critical care segment as REMI.
• Stratus Neuro: Emerging neurodiagnostics company focused on remote EEG monitoring and home-based brain monitoring services. Direct overlap with REMI's ambulatory/home seizure monitoring use case; smaller scale but targets the same outpatient neurology and rural-access segments.

Broad incumbents

• Medtronic (Neurology / Patient Monitoring): Large-cap medtech incumbent with a Neurology portfolio (e.g., BrainSense, StealthStation) and broader patient monitoring business. Comparable on neurology buyer access and adjacent neuro-monitoring workflows; potential acquirer or strategic partner given Epitel's complementary wireless EEG capability.
• Masimo: Large patient monitoring and pulse oximetry incumbent with a growing neuroscience/EEG portfolio (via SedLine, O3 regional oximetry, and related acquisitions). Comparable as a broad incumbent building into continuous neurological/physiological monitoring in hospital settings; significant overlap on ICU monitoring buyer relationships.

Direct peers

• Compumedics: Australian-based neurodiagnostics and sleep medical device manufacturer offering EEG systems for clinical and research use. Comparable in EEG monitoring product category and target neurology customer base; competes in ambulatory and in-hospital EEG segments that overlap directly with REMI's positioning.
• Natus Medical: Established neurodiagnostics medical device company offering EEG systems (wired and wireless) and related consumables for hospitals and neurology clinics. Directly comparable product category (clinical EEG) with much broader portfolio and larger sales force; serves the same hospital neurology, ICU, and ambulatory EEG buyers as Epitel.
• Ceribell: Developer of a rapid-response EEG system (Ceribell EEG Headband + cloud seizure detection AI) for hospital ICUs and emergency departments. Closest direct competitor to Epitel — both target rapid EEG initiation in critical care without an EEG technician, with AI-powered seizure detection. Highly relevant for head-to-head hospital sales comparisons.
• NeuroPace: Publicly-traded neuro device company with the RNS System for closed-loop responsive neurostimulation in epilepsy. Comparable end market (epilepsy care) and customer (neurologists/epileptologists); different mechanism (implanted device) but same disease and clinician call point.
• Wave Neuroscience: Neurological wearable and EEG analytics company with products spanning clinical and consumer neuro-monitoring. Overlaps with Epitel on wireless EEG hardware and AI-driven neurological signal analysis; relevant for competitive dynamics in ambulatory/wearable neurotech.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights8 records

Customer concentration

• Xx.com/WeAreEpitel
• Facebookfacebook.com/weareepitel

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds6 records

Investors9 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Epitel